{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:23:11Z","timestamp":1770081791697,"version":"3.49.0"},"reference-count":411,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharmthera.2025.108799","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:02:45Z","timestamp":1737676965000},"page":"108799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy"],"prefix":"10.1016","volume":"267","author":[{"given":"Sina","family":"Pakkhesal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shakouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Mosaddeghi-Heris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Kiani Nasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negin","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AmirMohammad","family":"Sharafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ahmadalipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2025.108799_bb0005","doi-asserted-by":"crossref","DOI":"10.1021\/jm00038a020","article-title":"(R)-Methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability","author":"Abadji","year":"1994","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0706873104","article-title":"Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step","author":"Adermark","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/nature15698","article-title":"Basomedial amygdala mediates top-down control of anxiety and fear","author":"Adhikari","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2009.12.002","article-title":"Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety","author":"Adhikari","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/cr0782067","article-title":"Enzymatic pathways that regulate endocannabinoid signaling in the nervous system","author":"Ahn","year":"2008","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0b013e3283564dfa","article-title":"The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature","author":"Aliczki","year":"2012","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2013.03.017","article-title":"Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice","author":"Aliczki","year":"2013","journal-title":"Hormones and Behavior"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0040","series-title":"Diagnostic and statistical manual of mental disorders","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135254","article-title":"The impact of sleep deprivation on sexual behaviors and FAAH expression in the prefrontal cortex of male rats","volume":"735","author":"Amini","year":"2020","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107100","article-title":"The study of rs324420 (C385A) polymorphism of the FAAH gene of the endocannabinoid system in patients with epilepsy and ADHD","author":"Anvar","year":"2023","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0055","doi-asserted-by":"crossref","DOI":"10.1124\/molpharm.122.000555","article-title":"A complete endocannabinoid signaling system modulates synaptic transmission between human induced pluripotent stem cell-derived neurons","author":"Asher","year":"2023","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706056","article-title":"Anxiogenic properties of an inverse agonist selective for \u03b13 subunit-containing GABA A receptors","author":"Atack","year":"2005","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB 2: A cannabinoid receptor with an identity crisis","author":"Atwood","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ph15040473","article-title":"Cannabinoid CB1 receptor involvement in the actions of CBD on anxiety and coping behaviors in mice","author":"Austrich-Olivares","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/lm.53303","article-title":"Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse","author":"Azad","year":"2003","journal-title":"Learning & Memory"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0080","doi-asserted-by":"crossref","DOI":"10.1101\/lm.741908","article-title":"Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala","author":"Azad","year":"2008","journal-title":"Learning & Memory"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0085","doi-asserted-by":"crossref","DOI":"10.1124\/mol.116.103465","article-title":"Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons","author":"Bagher","year":"2016","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.07.034","article-title":"Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers","author":"Bagher","year":"2017","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0095","doi-asserted-by":"crossref","DOI":"10.1134\/S0006297921070038","article-title":"Noncanonical activity of endocannabinoids and their receptors in central and peripheral synapses","author":"Balezina","year":"2021","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(04)00150-3","article-title":"Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin","author":"Bandell","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/15622975.2016.1190867","article-title":"Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition","author":"Bandelow","year":"2017","journal-title":"World Journal of Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108799_bb0110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)30230-2","article-title":"Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes","volume":"194","author":"Banerjee","year":"1975","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2004.06.006","article-title":"The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: In vivo and in vitro studies in CB1 receptor knockout mice","author":"Barna","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.03.010","article-title":"Cannabinoid CB 1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT 1A receptor activation","author":"Batista","year":"2019","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0125","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.149","article-title":"Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the \u03b22 subunit of GABAA receptors?","author":"Baur","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12270","article-title":"Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the \u03b22 subunit of GABAA receptors","author":"Baur","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2006.02.023","article-title":"TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents","author":"Bautista","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-018-0141-7","article-title":"Therapeutic endocannabinoid augmentation for mood and anxiety disorders: Comparative profiling of FAAH, MAGL and dual inhibitors","author":"Bedse","year":"2018","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2017.03.002","article-title":"Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety","author":"Bedse","year":"2017","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2020.01.015","article-title":"2-Arachidonoylglycerol modulation of anxiety and stress adaptation: From grass roots to novel therapeutics","author":"Bedse","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0155","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.20-17-06707.2000","article-title":"Disruption of arcuate\/paraventricular nucleus connections changes body energy balance and response to acute stress","author":"Bell","year":"2000","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-57371-7_3","article-title":"Endocannabinoids, stress, and negative affect","author":"Berger","year":"2017","journal-title":"Endocannabinoids and Lipid Mediators in Brain Functions"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0165","doi-asserted-by":"crossref","DOI":"10.1210\/endo-123-4-2117","article-title":"Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat","author":"Beyer","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010676.pub2","article-title":"Antidepressants versus placebo for panic disorder in adults","author":"Bighelli","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2009.05.021","article-title":"The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.tics.2007.05.008","article-title":"Neurocognitive mechanisms of anxiety: An integrative account","author":"Bishop","year":"2007","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0190","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.102.042960","article-title":"Deletion of the \u03b11 or \u03b22 subunit of GABAa receptors reduces actions of alcohol and other drugs","author":"Blednov","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","author":"Bluett","year":"2017","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24203672","article-title":"Cannabinoid receptor interacting protein 1a (CRIP1a): Function and structure","author":"Booth","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-007-0721-3","article-title":"Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of \u03949-tetrahydrocannabinol","author":"Boucher","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2015.12.005","article-title":"Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice","author":"Bowers","year":"2016","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010677.pub2","article-title":"Benzodiazepines versus placebo for panic disorder in adults","author":"Breilmann","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.638007","article-title":"Locus Coeruleus norepinephrine in learned behavior: Anatomical modularity and spatiotemporal integration in targets","author":"Breton-Provencher","year":"2021","journal-title":"Frontiers in Neural Circuits"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15769","article-title":"Fundamental neurochemistry review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy","author":"Bryson","year":"2023","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","author":"Busquets-Garcia","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/nn.4101","article-title":"Resolving the neural circuits of anxiety","author":"Calhoon","year":"2015","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2013.12.028","article-title":"Membrane lipids tune synaptic transmission by direct modulation of presynaptic potassium channels","author":"Carta","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: A heat-activated ion channel in the pain pathway","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00850","article-title":"The CB2 agonist \u03b2-caryophyllene in male and female rats exposed to a model of persistent inflammatory pain","author":"Ceccarelli","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2010.08.022","article-title":"MRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration","author":"Cespedes","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0260","article-title":"Exploring clinical applications and long-term effectiveness of benzodiazepines: An integrated perspective on mechanisms, imaging, and personalized medicine","author":"Chang","year":"2024","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2006.08.017","article-title":"Anxiolytic-like effect of asiaticoside in mice","author":"Chen","year":"2006","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0270","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1704065114","article-title":"Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake","author":"Chicca","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0275","doi-asserted-by":"crossref","DOI":"10.1210\/en.2007-0966","article-title":"A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release","author":"Chu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0280","doi-asserted-by":"crossref","DOI":"10.1210\/en.2006-1608","article-title":"A role for \u03b2-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","author":"Chu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-022-01755-9","article-title":"Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis","author":"Codagnone","year":"2022","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0290","article-title":"Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor","author":"Collado","year":"1998","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(99)00016-8","article-title":"Chronic treatment with CP-55,940 regulates corticotropin releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat","author":"Corchero","year":"1999","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-328X(99)00053-4","article-title":"Time-dependent differences of repeated administration with \u03949- tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by \u03bc-opioid and CB1-cannabinoid receptors in the caudate-putamen","author":"Corchero","year":"1999","journal-title":"Molecular Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0305","doi-asserted-by":"crossref","DOI":"10.1210\/en.2005-1649","article-title":"Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function","author":"Cota","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/S0028-3908(97)00110-X","article-title":"Action of \u03b4-9-tetrahydrocannabinol on GABA(A) receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice","author":"Coull","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0315","doi-asserted-by":"crossref","DOI":"10.1038\/12207","article-title":"Decreased GABA(A)-receptor clustering results in enhanced anxiety and a bias for threat cues","author":"Crestani","year":"1999","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(24)12233-X","article-title":"Molecular targets for the myorelaxant action of diazepam","author":"Crestani","year":"2001","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108799_bb0325","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0022-3565(25)38157-7","article-title":"Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats","volume":"265","author":"Criswell","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-9861(19960422)368:1<88::AID-CNE6>3.0.CO;2-G","article-title":"Fos expression in forebrain afferents to the hypothalamic paraventricular nucleus following swim stress","author":"Cullinan","year":"1996","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/cne.903320102","article-title":"Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis","author":"Cullinan","year":"1993","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/14656566.2017.1285907","article-title":"A meta-analysis of pharmacotherapy for social anxiety disorder: An examination of efficacy, moderators, and mediators","author":"Curtiss","year":"2017","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02514-2","article-title":"Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder","author":"Cutler","year":"2023","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0350","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.ne.15.030192.002033","article-title":"The role of the amygdala in fear and anxiety","author":"Davis","year":"1992","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108287","article-title":"Differential glutamatergic and GABAergic contributions to the tetrad effects of \u03949-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor","author":"De Giacomo","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: From adaptation to disease","author":"De Kloet","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12786","article-title":"The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice","author":"De Moura","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2005.05.021","article-title":"Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels","author":"De Petrocellis","year":"2005","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0375","doi-asserted-by":"crossref","DOI":"10.1007\/s11481-009-9177-z","article-title":"Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: Focus on G-protein-coupled receptors and transient receptor potential channels","author":"De Petrocellis","year":"2010","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2007.01.008","article-title":"Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): Effect of cAMP, cannabinoid CB1 receptors and endovanilloids","author":"De Petrocellis","year":"2007","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0385","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.107.134809","article-title":"Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8","author":"De Petrocellis","year":"2008","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2004.06.020","article-title":"Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol","author":"De Witte","year":"2004","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0395","doi-asserted-by":"crossref","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of biased \u03b2-arrestin-mediated signaling downstream from the cannabinoid 1 receptor","author":"Delgado-Peraza","year":"2016","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1129946","article-title":"Epigenetic (re)programming of gene expression changes of CB1R and FAAH in the medial prefrontal cortex in response to early life and adolescence stress exposure","author":"Demaili","year":"2023","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(98)01175-2","article-title":"Interactions between synthetic vanilloids and the endogenous cannabinoid system","author":"Di Marzo","year":"1998","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action","author":"Di Marzo","year":"1998","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0415","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.23-12-04850.2003","article-title":"Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism","author":"Di","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0420","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of \u03b13-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","author":"Dias","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex","author":"Diez-Alarcia","year":"2016","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0430","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2012.100","article-title":"Acute stress increases circulating anandamide and other n-acylethanolamines in healthy humans","author":"Dlugos","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/0022-4731(80)90209-5","article-title":"Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa","author":"Doerr","year":"1980","journal-title":"Journal of Steroid Biochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109730","article-title":"Crh receptor priming in the bed nucleus of the stria terminalis (BNST) induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety","author":"Donner","year":"2020","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2019.10.015","article-title":"Stress-induced plasticity and functioning of ventral tegmental dopamine neurons","author":"Douma","year":"2020","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0450","article-title":"Neural circuits in anxiety and stress disorders: A focused review","author":"Duval","year":"2015","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/0196-9781(85)90323-7","article-title":"Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats","author":"Eaves","year":"1985","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: Uses, dangers, and clinical considerations","author":"Edinoff","year":"2021","journal-title":"Neurology International"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0465","doi-asserted-by":"crossref","DOI":"10.1042\/bj3090837","article-title":"Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase","author":"Eggerickx","year":"1995","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0470","doi-asserted-by":"crossref","DOI":"10.1097\/YPG.0000000000000249","article-title":"Transient receptor potential vanilloid 1 antagonism in neuroinflammation, neuroprotection and epigenetic regulation: Potential therapeutic implications for severe psychiatric disorders treatment","author":"Escelsior","year":"2020","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0475","doi-asserted-by":"crossref","DOI":"10.1210\/en.2010-0285","article-title":"Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling","author":"Evanson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/j.1552-4604.1981.tb02617.x","article-title":"The efficacy and safety of Nabilone (A synthetic cannabinoid) in the treatment of anxiety","author":"Fabre","year":"1981","journal-title":"The Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0485","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0315-14.2014","article-title":"Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission","author":"Fawley","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2009.05.011","article-title":"Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance","author":"Finn","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0495","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.1982.tb08802.x","article-title":"Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of \u03949-tetrahydrocannabinol","author":"Fitton","year":"1982","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U","article-title":"Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat","author":"Floyd","year":"2000","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0505","article-title":"FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class includes potential for abuse, addiction, and other serious risks","author":"Food and Drug Administration","year":"2020","journal-title":"FDA Drug Safety Communications, Published September, 23"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2017.08.008","article-title":"Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development","author":"Ford","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0515","doi-asserted-by":"crossref","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","author":"Fredriksson","year":"2003","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0520","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-epilepsy-gaba-receptor","article-title":"GABAA receptor variants in epilepsy","author":"Fu","year":"2022","journal-title":"Epilepsy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0525","doi-asserted-by":"crossref","DOI":"10.1089\/neu.2018.5854","article-title":"A novel role for the endocannabinoid system in ameliorating motivation for alcohol drinking and negative behavioral affect after traumatic brain injury in rats","author":"Fucich","year":"2019","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/glia.22845","article-title":"Alkylindole-sensitive receptors modulate microglial cell migration and proliferation","author":"Fung","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers","author":"Gabbott","year":"2005","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2007.11.075","article-title":"Synaptic physiology of central CRH system","author":"Gallagher","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0545","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01625.x","article-title":"Chronic blockade of cannabinoid CB 2 receptors induces anxiolytic-like actions associated with alterations in GABA A receptors","author":"Garc\u00eda-Guti\u00e9rrez","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0550","doi-asserted-by":"crossref","DOI":"10.1177\/0269881109106910","article-title":"The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines","author":"Garc\u00eda-Guti\u00e9rrez","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0555","doi-asserted-by":"crossref","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","author":"Garc\u00eda-Guti\u00e9rrez","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0560","doi-asserted-by":"crossref","DOI":"10.1097\/YIC.0000000000000147","article-title":"Pregabalin for generalized anxiety disorder: An updated systematic review and meta-analysis","author":"Generoso","year":"2017","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0565","doi-asserted-by":"crossref","DOI":"10.1212\/CON.0000000000000607","article-title":"Diagnosis and management of anxiety disorders","author":"Giacobbe","year":"2018","journal-title":"Continuum Lifelong Learning in Neurology."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0575","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a G(s) linkage to the CB1 receptor","author":"Glass","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2013.05.013","article-title":"Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze","author":"Gobira","year":"2013","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0585","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhu045","article-title":"Control of inhibition by the direct action of cannabinoids on GABAA receptors","author":"Golovko","year":"2015","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0590","doi-asserted-by":"crossref","DOI":"10.1080\/14656566.2018.1472767","article-title":"Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: A meta-analytic review","author":"Gomez","year":"2018","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0595","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00138","article-title":"Effects of different stressors are modulated by different neurobiological systems: The role of GABA-A versus CB1 receptor gene variants in anxiety and depression","author":"Gonda","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain","author":"Gong","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2008.03.004","article-title":"Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders","author":"Gorzalka","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0610","doi-asserted-by":"crossref","DOI":"10.1089\/can.2017.0015","article-title":"N-arachidonoyl dopamine: A novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities","author":"Grabiec","year":"2017","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0615","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.1981.tb01099.x","article-title":"Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy","author":"Greenblatt","year":"1981","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108799_bb0620","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"The Ochsner Journal"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0625","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22509-1","article-title":"Real-world stress resilience is associated with the responsivity of the locus coeruleus","author":"Grueschow","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0630","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1721339115","article-title":"Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses","author":"Haj-Dahmane","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0635","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.2002.02192.x","article-title":"The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety","author":"Haller","year":"2002","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0640","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2007.05476.x","article-title":"Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission","author":"Haller","year":"2007","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0645","doi-asserted-by":"crossref","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: Convergent genetic and pharmacological evidence with CB1-specific agents","author":"Haller","year":"2004","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-2999(00)00059-5","article-title":"Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice","author":"Hao","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0655","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-015-4188-3","article-title":"The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: A multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders","author":"Hassanzadeh","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0660","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0693-10.2010","article-title":"Amygdala-specific reduction of \u03b11-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice","author":"Heldt","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0665","doi-asserted-by":"crossref","DOI":"10.1038\/nrn.2016.94","article-title":"Region-specific roles of the corticotropin-releasing factor-urocortin system in stress","author":"Henckens","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107847","article-title":"C-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner","author":"Henderson-Redmond","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0675","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","author":"Herkenham","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0680","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study","author":"Herkenham","year":"1991","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/B978-008045046-9.00097-8","article-title":"Stress response: Neural and feedback regulation of the HPA axis","author":"Herman","year":"2009","journal-title":"Encyclopedia of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0690","doi-asserted-by":"crossref","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary- adrenocortical stress response","author":"Herman","year":"2016","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2005.08.006","article-title":"Limbic system mechanisms of stress regulation: Hypothalamo-pituitary- adrenocortical axis","author":"Herman","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0700","doi-asserted-by":"crossref","DOI":"10.1007\/s000180300052","article-title":"Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response","author":"Hermann","year":"2003","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of anxiety-like responsiveness to the cannabinoid CB 1 receptor agonist HU-210 following chronic stress","author":"Hill","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0710","doi-asserted-by":"crossref","DOI":"10.1017\/S0033291723002465","article-title":"The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses","author":"Hill","year":"2023","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2010.03.005","article-title":"Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo","author":"Hill","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0720","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","author":"Hill","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-6980(00)00051-4","article-title":"Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol","author":"Hillard","year":"2000","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/bs.irn.2015.10.001","article-title":"The endocannabinoid signaling system in the CNS: A primer","author":"Hillard","year":"2015","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0735","doi-asserted-by":"crossref","DOI":"10.1016\/bs.mie.2017.06.017","article-title":"Endocannabinoid transport proteins: Discovery of tools to study sterol carrier protein-2","author":"Hillard","year":"2017","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2004.12.012","article-title":"Accumulation of anandamide: Evidence for cellular diversity","author":"Hillard","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2016.3","article-title":"Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking","author":"Holleran","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(17)30513-8","article-title":"The lancet psychiatry commission on psychological treatments research in tomorrow\u2019s science","author":"Holmes","year":"2018","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/biof.1911","article-title":"Fatty acid amide hydrolase C385A polymorphism affects susceptibility to various diseases","author":"Hosseinzadeh Anvar","year":"2023","journal-title":"BioFactors"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0760","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.7b00194","article-title":"The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites","author":"Hsu","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2012.03.035","article-title":"Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism","author":"Huang","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0770","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","author":"Huang","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/cne.903080210","article-title":"Efferent projections of the infralimbic cortex of the rat","author":"Hurley","year":"1991","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0780","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.2005.094219","article-title":"Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell","author":"Isokawa","year":"2005","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0785","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1784-10.2010","article-title":"Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors","author":"Ivy","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0790","doi-asserted-by":"crossref","DOI":"10.1038\/nature14188","article-title":"From circuits to behaviour in the amygdala","author":"Janak","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0795","doi-asserted-by":"crossref","DOI":"10.3238\/arztebl.2015.0001","article-title":"The problems of long-term treatment with benzodiazepines and related substances","author":"Janhsen","year":"2015","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0800","doi-asserted-by":"crossref","DOI":"10.1186\/s43045-023-00315-3","article-title":"Epidemiology of anxiety disorders: Global burden and sociodemographic associations","author":"Javaid","year":"2023","journal-title":"Middle East Current Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0805","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M111.304907","article-title":"Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors","author":"Kaczocha","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4530(97)00026-7","article-title":"Diazepam attenuation of restraint stress-induced corticosterone levels is enhanced by prior exposure to repeated restraint","author":"Kalman","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2010.196","article-title":"Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala","author":"Kamprath","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0820","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","author":"Katona","year":"2012","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0825","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","author":"Katona","year":"2001","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0830","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","author":"Katona","year":"1999","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0835","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0309-06.2006","article-title":"Molecular composition of the endocannabinoid system at glutamatergic synapses","author":"Katona","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0840","article-title":"Pharmacology of GABA and its receptors","author":"Kaur","year":"2020","journal-title":"Frontiers in Pharmacology of Neurotransmitters"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2023.04.069","article-title":"The burden of anxiety among a nationally representative US adult population","author":"Kavelaars","year":"2023","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137567","article-title":"Benzodiazepine derivatives for the treatment of neuropharmacological disorders and pain management: Docking investigations and in-vivo studies","author":"Khan","year":"2024","journal-title":"Journal of Molecular Structure"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay","author":"Kinsey","year":"2011","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0860","doi-asserted-by":"crossref","DOI":"10.1201\/9780367814373-5","article-title":"Benzodiazepines and related substances: Therapeutic uses and problems","author":"Kitzen","year":"2021","journal-title":"Naturally Occurring Benzodiazepines, Endozepines, and their Receptors."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2006.07.007","article-title":"Pharmacological and genetic influences on hole-board behaviors in mice","author":"Kliethermes","year":"2006","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb0870","doi-asserted-by":"crossref","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0875","doi-asserted-by":"crossref","DOI":"10.1002\/hipo.20772","article-title":"The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB 1 receptors and modulated by TRPA1 and Ca v2.2 channels","author":"Koch","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0880","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-023-00724-7","article-title":"GABA tone regulation and its cognitive functions in the brain","author":"Koh","year":"2023","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0885","doi-asserted-by":"crossref","DOI":"10.1515\/jbcpp-2015-0058","article-title":"Targeting the endocannabinoid system to treat anxiety-related disorders","author":"Korem","year":"2016","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0890","doi-asserted-by":"crossref","DOI":"10.1503\/jpn.210187","article-title":"Peptidergic neurons of the Edinger\u2013Westphal nucleus express TRPA1 ion channel that is downregulated both upon chronic variable mild stress in male mice and in humans who died by suicide","author":"Kormos","year":"2022","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2013.05.003","article-title":"CRH: The link between hormonal-, metabolic- and behavioral responses to stress","author":"Kov\u00e1cs","year":"2013","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2018.08.012","article-title":"Amygdala reactivity and connectivity during social and non-social aversive stimulation in social anxiety disorder","author":"Kraus","year":"2018","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells","author":"Kreitzer","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000709","article-title":"Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex","author":"Lafourcade","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0915","doi-asserted-by":"crossref","DOI":"10.1677\/JOE-08-0453","article-title":"GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis","author":"Lan","year":"2009","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0920","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.156","article-title":"Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat","author":"Lange","year":"2017","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2020.04.126","article-title":"\u03b3-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases","author":"\u0141\u0105tka","year":"2020","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0930","doi-asserted-by":"crossref","DOI":"10.2337\/db08-1237","article-title":"GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell","author":"Lauffer","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2017.05.165","article-title":"GPR3 and GPR6, novel molecular targets for cannabidiol","author":"Laun","year":"2017","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108799_bb0940","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-3565(25)31832-X","article-title":"Relationships between plasma corticosteroids and benzodiazepines in stress","volume":"211","author":"Le Fur","year":"1979","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0945","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.08-07-02517.1988","article-title":"Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear","author":"LeDoux","year":"1988","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0950","article-title":"Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex","author":"Lee","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0955","article-title":"Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals","author":"Lenkey","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0960","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021714","article-title":"Patterns of coupled theta activity in amygdala-hippocampal-prefrontal cortical circuits during fear extinction","author":"Lesting","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0965","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-014-8651-7","article-title":"Sterol carrier protein-2: Binding protein for endocannabinoids","author":"Liedhegner","year":"2014","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0970","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3582","article-title":"Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety","author":"Likhtik","year":"2014","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0975","article-title":"Separate and combined effects of the GABAB agonist baclofen and \u03949-THC in humans discriminating \u03949-THC","author":"Lile","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0980","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179695","article-title":"Regulation of expression of cannabinoid CB2 and serotonin 5HT1A receptor complexes by cannabinoids in animal models of hypoxia and in oxygen\/glucose-deprived neurons","author":"Lillo","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0985","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2015.284","article-title":"Endocannabinoid modulation of predator stress-induced long-term anxiety in rats","author":"Lim","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0990","article-title":"Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate","author":"Liu","year":"2005","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb0995","doi-asserted-by":"crossref","DOI":"10.1210\/en.2007-0745","article-title":"The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior","author":"Liu","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1000","article-title":"Corticotropin-releasing factor and urocortin I modulate excitatory glutamatergic synaptic transmission","author":"Liu","year":"2004","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1005","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.1c00048","article-title":"Functional selectivity of a biased cannabinoid-1 receptor (CB1R) antagonist","author":"Liu","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1010","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1015","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2014.198","article-title":"Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain","author":"Lomazzo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1020","doi-asserted-by":"crossref","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1025","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.598812","article-title":"Putative activation of the CB1 cannabinoid receptors prevents anxiety-like behavior, oxidative stress, and GABA decrease in the brain of zebrafish submitted to acute restraint stress","author":"Lucas Luz","year":"2021","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042101","article-title":"Influence of GABAA receptor \u03b1 subunit isoforms on the benzodiazepine binding site","author":"L\u00fcscher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1035","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","author":"Lutz","year":"2020","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1040","doi-asserted-by":"crossref","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","author":"Lutz","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","author":"Macki","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1050","article-title":"Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus","author":"Makino","year":"1994","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1055","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2020.22.3\/rmaldonado","article-title":"The endocannabinoid system in modulating fear, anxiety, and stress","author":"Maldonado","year":"2020","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1060","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S89485","article-title":"Quetiapine monotherapy in acute treatment of generalized anxiety disorder: A systematic review and meta-analysis of randomized controlled trials","author":"Maneeton","year":"2016","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(96)00326-3","article-title":"Activation of the cannabinoid receptor by \u03949-tetrahydrocannabinol reduces \u03b3-aminobutyric acid uptake in the globus pallidus","author":"Maneuf","year":"1996","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(99)01756-4","article-title":"Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of \u03949-tetrahydrocannabinol in rats","author":"Manzanares","year":"1999","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/nature19318","article-title":"Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala","author":"Marcinkiewcz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1080","doi-asserted-by":"crossref","DOI":"10.1038\/nn.2430","article-title":"Self-modulation of neocortical pyramidal neurons by endocannabinoids","author":"Marinelli","year":"2009","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1085","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2004.03574.x","article-title":"Functional mapping of GABAA receptor subtypes in the amygdala","author":"Marowsky","year":"2004","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1090","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3303-06.2007","article-title":"Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice","author":"Marsch","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1095","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-74349-3_10","article-title":"Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord: Circuitries and neurochemistry","author":"Marsicano","year":"2008","journal-title":"Cannabinoids and the Brain"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1100","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","author":"Marsicano","year":"1999","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1105","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-2999(97)01560-4","article-title":"Characterization of the acute endocrine actions of (\u2212)-11-hydroxy-\u03948-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats","author":"Mart\u00edn-Calder\u00f3n","year":"1998","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2003.11.004","article-title":"Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain","author":"Mato","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1115","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.6b00339","article-title":"Cell type-specific tandem affinity purification of the mouse hippocampal CB1 receptor-associated proteome","author":"Mattheus","year":"2016","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2015.07.002","article-title":"CRH engagement of the locus coeruleus noradrenergic system mediates stress-induced anxiety","author":"McCall","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18247.014","article-title":"Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior","author":"McCall","year":"2017","journal-title":"ELife"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1130","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(01)00380-3","article-title":"Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: High concentrations in a subpopulation of cholecystokinin-containing interneurons","author":"McDonald","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1135","article-title":"Projections of the medial and lateral prefrontal cortices to the amygdala: A Phaseolus vulgaris leucoagglutinin study in the rat","author":"Mcdonald","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2014.02.006","article-title":"A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior","author":"McLaughlin","year":"2014","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1145","doi-asserted-by":"crossref","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","author":"Mechoulam","year":"1995","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1150","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-61663-2_8","article-title":"Modulation of noradrenergic and serotonergic systems by cannabinoids: Electrophysiological, neurochemical and behavioral evidence","author":"Mendiguren","year":"2021","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1155","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1160","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2017-0262","article-title":"Structural changes at the myrtenol backbone reverse its positive allosteric potential into inhibitory GABA A receptor modulation","author":"Milanos","year":"2018","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1165","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-024-02844-9","article-title":"Resting-state amygdala subregion and precuneus connectivity provide evidence for a dimensional approach to studying social anxiety disorder","author":"Mizzi","year":"2024","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1170","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-024-01844-z","article-title":"Late-adolescent onset of prefrontal endocannabinoid control of hippocampal and amygdalar inputs and its impact on trace-fear conditioning behavior","author":"Molla","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/bs.mie.2017.05.005","article-title":"Methods for the development of in silico GPCR models","author":"Morales","year":"2017","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1185","doi-asserted-by":"crossref","DOI":"10.2174\/0929867323666160425113836","article-title":"Advances towards the discovery of GPR55 ligands","author":"Morales","year":"2016","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1190","doi-asserted-by":"crossref","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB1, non-CB2 cannabinoid related G-protein-coupled receptors","author":"Morales","year":"2017","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2016.08.020","article-title":"Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety","author":"Morena","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1205","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2017.12","article-title":"Singular location and signaling profile of adenosine A2A-cannabinoid CB1 receptor heteromers in the dorsal striatum","author":"Moreno","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1210","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820930321","article-title":"The role of the locus coeruleus in the generation of pathological anxiety","author":"Morris","year":"2020","journal-title":"Brain and Neuroscience Advances"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1215","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-022-01130-5","article-title":"The central nucleus of the amygdala and the construction of defensive modes across the threat-imminence continuum","author":"Moscarello","year":"2022","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108799_bb1220","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3565(24)35181-X","article-title":"Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture","volume":"291","author":"Mu","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1225","doi-asserted-by":"crossref","DOI":"10.1038\/nn1123","article-title":"Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress","author":"M\u00fcller","year":"2003","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034586","article-title":"Complex control of GABA(a) receptor subunit mRNA expression: Variation, covariation, and genetic regulation","author":"Mulligan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1235","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2007.11.001","article-title":"Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice","author":"Naderi","year":"2008","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb1240","doi-asserted-by":"crossref","DOI":"10.1016\/0741-8329(95)00013-H","article-title":"[3H] MK-801 binding in various brain regions of rat lines selected for differential alcohol sensitivity","author":"N\u00e4kki","year":"1995","journal-title":"Alcohol"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1245","doi-asserted-by":"crossref","DOI":"10.1038\/nature14366","article-title":"A circuit mechanism for differentiating positive and negative associations","author":"Namburi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2017.02.002","article-title":"The insula: An underestimated brain area in clinical neuroscience, psychiatry, and neurology","author":"Namkung","year":"2017","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1260","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes","author":"Navarro","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1265","doi-asserted-by":"crossref","DOI":"10.1097\/00001756-199701200-00023","article-title":"Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat","author":"Navarro","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2023.04.017","article-title":"Expression of the transient receptor potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice","author":"Ngoc","year":"2023","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.117878","article-title":"A high-resolution in vivo atlas of the human brain\u2019s benzodiazepine binding site of GABAA receptors","author":"N\u00f8rgaard","year":"2021","journal-title":"NeuroImage"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1280","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3323","article-title":"Genetic variation of the 5-HT1A rs6295, 5-HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients","author":"Obermanns","year":"2023","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1285","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV119.007060","article-title":"Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials","author":"O\u2019Brien","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101239","article-title":"Endocannabinoid signaling in adult hippocampal neurogenesis: A mechanistic and integrated perspective","author":"Oddi","year":"2023","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1295","doi-asserted-by":"crossref","DOI":"10.3390\/biom10121609","article-title":"Cannabinoid receptor interacting protein 1a (CRIP1a) in health and disease","author":"Oliver","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108799_bb1300","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1305","doi-asserted-by":"crossref","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity","author":"Onaivi","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1310","article-title":"The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans","author":"\u00d6ng\u00fcr","year":"2000","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1315","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.691219","article-title":"Tonic endocannabinoid signaling gates synaptic plasticity in dorsal raphe nucleus serotonin neurons through peroxisome proliferator-activated receptors","author":"Oubraim","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1320","doi-asserted-by":"crossref","DOI":"10.1002\/syn.890040304","article-title":"Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain","author":"Owens","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1325","article-title":"The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies","author":"Owens","year":"1993","journal-title":"Ciba Foundation Symposium"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108799_bb1330","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0022-3565(25)20232-4","article-title":"The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: Acute time course, chronic treatment and abrupt withdrawal","volume":"258","author":"Owens","year":"1991","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1335","doi-asserted-by":"crossref","DOI":"10.1210\/edrv.22.4.0436","article-title":"Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders","author":"Pac\u00e1k","year":"2001","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1340","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M705699200","article-title":"The F-loop of the GABAa receptor \u03b32 subunit contributes to benzodiazepine modulation","author":"Padgett","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1345","first-page":"1","article-title":"GABAA receptor modulation by the endocannabinoid system: Insights into the regulatory mechanisms involving glutamine synthetase and MAPK mediators","volume":"2024","author":"Pakkhesal","year":"2024","journal-title":"Human Cell"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1350","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-019-1026-z","article-title":"Cannabinoid regulation of fear and anxiety: An update","author":"Papagianni","year":"2019","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1355","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88750-2","article-title":"CB1 antagonism increases excitatory synaptogenesis in a cortical spheroid model of fetal brain development","author":"Papariello","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1360","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.660718","article-title":"Dichotomic hippocampal transcriptome after glutamatergic vs. GABAergic deletion of the cannabinoid CB1 receptor","author":"Pascual Cuadrado","year":"2021","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","author":"Patel","year":"2017","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1370","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling","author":"Patel","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1375","doi-asserted-by":"crossref","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1380","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-00936-w","article-title":"The effects of FAAH inhibition on the neural basis of anxiety-related processing in healthy male subjects: A randomized clinical trial","author":"Paulus","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1385","doi-asserted-by":"crossref","DOI":"10.1002\/cne.10118","article-title":"Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus","author":"Pawelzik","year":"2002","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1390","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14674","article-title":"Microglial activation in the lateral amygdala promotes anxiety-like behaviors in mice with chronic moderate noise exposure","author":"Peng","year":"2024","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1395","doi-asserted-by":"crossref","DOI":"10.1016\/0024-3205(85)90635-6","article-title":"Sex differences in the response of rats to drugs affecting GABAergic transmission","author":"Peri\u010di\u0107","year":"1985","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1400","doi-asserted-by":"crossref","DOI":"10.1007\/BF01271558","article-title":"Sex differences in conflict behaviour and in plasma corticosterone levels","author":"Peri\u010di\u0107","year":"1995","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1405","doi-asserted-by":"crossref","DOI":"10.1007\/BF00261432","article-title":"Effects of diazepam on conflict behaviour and on plasma corticosterone levels in male and female rats","author":"Peri\u010di\u0107","year":"1996","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108799_bb1410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British journal of pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1415","doi-asserted-by":"crossref","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1425","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-020-01912-7","article-title":"Molecular, structural, functional, and pharmacological sites for vesicular glutamate transporter regulation","author":"Pietrancosta","year":"2020","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1430","article-title":"Catecholamine turnover in the brain and the regulation of luteinizing hormone and corticosterone in starved male rats","author":"Pirke","year":"1982","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1435","doi-asserted-by":"crossref","DOI":"10.2174\/092986710790980014","article-title":"From surface to nuclear receptors: The endocannabinoid family extends its assets","author":"Pistis","year":"2010","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1440","doi-asserted-by":"crossref","DOI":"10.1007\/BF01244876","article-title":"Inhibitory effect of diazepam on the activity of the hypothalamic-pituitary-adrenal axis in female rats","author":"Pivac","year":"1993","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172833","article-title":"Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice","author":"Poleszak","year":"2020","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb1450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008869","article-title":"Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis","author":"Puente","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1455","doi-asserted-by":"crossref","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling","author":"Puighermanal","year":"2009","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115800","article-title":"Current status of GABA receptor subtypes in analgesia","author":"Qian","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1465","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","author":"Qin","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2010.08.003","article-title":"The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics","author":"Raehal","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2014.01.012","article-title":"Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses","author":"Ramikie","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1480","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24071432","article-title":"Modulation of endocannabinoid-binding receptors in human neuroblastoma cells by tunicamycin","author":"Rapino","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1485","article-title":"CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl) -6H-pyrrolo[3,2,1 ij]quinolin-6-one]-induced hypothermia","author":"Rawls","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1490","article-title":"N-methyl-D-aspartate antagonists and WIN 55212\u20132 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl) -6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia","author":"Rawls","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1495","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2010.64","article-title":"Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation","author":"Regev","year":"2011","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1500","doi-asserted-by":"crossref","DOI":"10.1007\/s00429-017-1411-5","article-title":"Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons","author":"Remmers","year":"2017","journal-title":"Brain Structure & Function"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1505","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA B receptors in the balance of gabaergic and glutamatergic neurotransmission","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2005.03.002","article-title":"Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety","author":"Rezayat","year":"2005","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063203","article-title":"Beta-caryophyllene, a cannabinoid receptor type 2 selective agonist, in emotional and cognitive disorders","author":"Ricardi","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2023.12.043","article-title":"Care trajectories of individuals with anxiety disorders: A retrospective cohort study","author":"Roberge","year":"2024","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2013.11.026","article-title":"Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: Effects of indirect agonists and comparison of male and female mice","author":"Roberts","year":"2014","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb1530","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0704904","article-title":"Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons","author":"Roberts","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1535","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2017.03.061","article-title":"Anxious behavior induces elevated hippocampal Cb2 receptor gene expression","author":"Robertson","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1540","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-321400","article-title":"The translational neural circuitry of anxiety","author":"Robinson","year":"2019","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1545","doi-asserted-by":"crossref","DOI":"10.1097\/00008877-200509000-00013","article-title":"Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-na\u00efve and plus-maze-experienced mice","author":"Rodgers","year":"2005","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1550","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.2003.02548.x","article-title":"\u201cOne-trial sensitization\u201d to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze","author":"Rodgers","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1555","doi-asserted-by":"crossref","DOI":"10.1002\/cne.903320109","article-title":"Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat","author":"Roland","year":"1993","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1560","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<298::AID-SYN7>3.0.CO;2-6","article-title":"Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to \u03949- tetrahydrocannabinol","author":"Romero","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1565","doi-asserted-by":"crossref","DOI":"10.1016\/S0024-3205(97)01117-X","article-title":"The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake","author":"Romero","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1570","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.5346-07.2008","article-title":"Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum","author":"Rossi","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1575","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","author":"Rubino","year":"2008","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1580","doi-asserted-by":"crossref","DOI":"10.1038\/sj.npp.1301330","article-title":"Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral \u03949-tetrahydrocannabinol in rats","author":"Rubino","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1585","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.4171-12.2013","article-title":"Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: Distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions","author":"Ruehle","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1590","doi-asserted-by":"crossref","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","author":"Ruehle","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1595","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.14099","article-title":"Discovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouse","author":"Ruehle","year":"2017","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116052","article-title":"Investigating selectivity and bias for G protein subtypes and \u03b2-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor","author":"Ryalls","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1605","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2004.11.085","article-title":"Identification and characterisation of a novel splice variant of the human CB1 receptor","author":"Ryberg","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1610","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-009-0030-9","article-title":"Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice","author":"Saber-Tehrani","year":"2010","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2006.10.076","article-title":"Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cells","author":"Sakamoto","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1620","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108684","article-title":"Female but not male rats show biphasic effects of low doses of \u03949-tetrahydrocannabinol on anxiety: Can cannabidiol interfere with these effects?","author":"Salviato","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1625","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2016.10.031","article-title":"Involvement of CB1 and TRPV1 receptors located in the ventral medial prefrontal cortex in the modulation of stress coping behavior","author":"Sartim","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1630","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12423","article-title":"Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders","author":"Schiele","year":"2018","journal-title":"Genes, Brain, and Behavior"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1635","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3234-13.2014","article-title":"Gap junctions in the ventral hippocampal-medial prefrontal pathway are involved in anxiety regulation","author":"Schoenfeld","year":"2014","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1640","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4530(97)00099-1","article-title":"Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load","author":"Schulkin","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1645","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","author":"Sciolino","year":"2011","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1650","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-019-0413-7","article-title":"Human brain transcriptome analysis finds region- and subject-specific expression signatures of GABAAR subunits","author":"Sequeira","year":"2019","journal-title":"Communications Biology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1655","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-018-0055-3","article-title":"Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake","author":"Serrano","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1660","doi-asserted-by":"crossref","DOI":"10.1002\/cne.902900205","article-title":"Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin","author":"Sesack","year":"1989","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1665","doi-asserted-by":"crossref","DOI":"10.1016\/0006-3223(86)90003-X","article-title":"Antianxiety effect of cannabis: Involvement of central benzodiazepine receptors","author":"Sethi","year":"1986","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1670","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101301","article-title":"Cannabinoids and cannabinoid receptors: The story so far","author":"Shahbazi","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1675","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104635","article-title":"Rapid treatments for depression: Endocannabinoid system as a therapeutic target","volume":"137","author":"Sharafi","year":"2022","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1680","article-title":"Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior","author":"Shen","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1685","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(00)02019-9","article-title":"Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior","author":"Shepard","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1690","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2009.04.029","article-title":"Chronically elevated corticosterone in the dorsolateral bed nuclei of stria terminalis increases anxiety-like behavior","author":"Shepard","year":"2009","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1695","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABA A receptor pharmacology: Drugs interacting with the \u03b1 +\u03b2 - interface","author":"Sieghart","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1700","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABA A receptors","author":"Sigel","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1705","doi-asserted-by":"crossref","DOI":"10.2174\/1874467213666200510004622","article-title":"Anticonvulsant, anxiolytic and antidepressant properties of the \u03b2-caryophyllene in Swiss mice: Involvement of benzodiazepine-GABAAergic, serotonergic and nitrergic systems","author":"da Silva Oliveira","year":"2020","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1710","article-title":"Effects of chronic treatment with \u03949-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTP\u03b3S autoradiography in rat brain","author":"Sim","year":"1996","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1715","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115261","article-title":"Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families","author":"Simard","year":"2022","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1720","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2011.188","article-title":"Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety","author":"Sink","year":"2013","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1725","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2008.09.014","article-title":"Entrainment of neocortical neurons and gamma oscillations by the hippocampal theta rhythm","author":"Sirota","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1730","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.20-03-01240.2000","article-title":"Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems","author":"Skelton","year":"2000","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1735","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis","author":"Slee","year":"2019","journal-title":"The Lancet"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1740","article-title":"Weeding out bad waves: Towards selective cannabinoid circuit control in epilepsy","author":"Soltesz","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1745","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0493-18.2018","article-title":"Selective role of RGS9-2 in regulating retrograde synaptic signaling of indirect pathway medium spiny neurons in dorsal striatum","author":"Song","year":"2018","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2022.102185","article-title":"The regional and cellular distribution of GABAA receptor subunits in the human amygdala","author":"Song","year":"2022","journal-title":"Journal of Chemical Neuroanatomy"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1755","doi-asserted-by":"crossref","DOI":"10.1006\/geno.1995.1154","article-title":"Molecular cloning and chromosomal localization of human genes encoding three closely related G protein-coupled receptors","author":"Song","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1760","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01177-7","article-title":"Fear extinction learning and anandamide: An fMRI study in healthy humans","author":"Spohrs","year":"2021","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1765","doi-asserted-by":"crossref","DOI":"10.3109\/10253890.2015.1004537","article-title":"Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis","author":"Stamper","year":"2015","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1770","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.12137","article-title":"Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus","author":"Steindel","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1775","doi-asserted-by":"crossref","DOI":"10.1016\/S0079-6123(08)00433-0","article-title":"Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis","author":"Steiner","year":"2008","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1780","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1785","article-title":"The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamicpituitary-adrenal axis activity in female rats","author":"Strac","year":"2012","journal-title":"Croatian Medical Journal"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1790","doi-asserted-by":"crossref","DOI":"10.1054\/plef.2001.0356","article-title":"Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance","author":"Sugiura","year":"2002","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1795","doi-asserted-by":"crossref","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain","author":"Sugiura","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1800","article-title":"The role of the corticotropin-releasing hormone and its receptors in the regulation of stress response","author":"Sukhareva","year":"2021","journal-title":"avilovskii Zhurnal Genetiki i Selektsii"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1805","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2011.166","article-title":"Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: A potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation","author":"Sumislawski","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1810","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-04519-z","article-title":"CRHR1 antagonist alleviates LPS-induced depression-like behaviour in mice","author":"Sun","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1815","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-03986-z","article-title":"Electroacupuncture alleviates hyperalgesia and anxiety-like behaviors in pain memory model rats through activation of GABAergic neurons and GABA receptor in the rostral anterior cingulate cortex","author":"Sun","year":"2024","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1820","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2017.10.015","article-title":"Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress","author":"Surkin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1825","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3087-11.2011","article-title":"An anxiolytic role for CRF receptor type 1 in the globus pallidus","author":"Sztainberg","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1830","doi-asserted-by":"crossref","DOI":"10.1016\/0006-8993(91)91677-S","article-title":"Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: An anterograde tracer PHA-L study","author":"Takagishi","year":"1991","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1835","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00087","article-title":"Endocannabinoid modulation of microglial phenotypes in neuropathology","author":"Tanaka","year":"2020","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1840","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M700911200","article-title":"Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth","author":"Tanaka","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1845","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02448-9","article-title":"NAPE-PLD deletion in stress-TRAPed neurons results in an anxiogenic phenotype","author":"Tevosian","year":"2023","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1850","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-023-01728-8","article-title":"Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: Past, present, and future","author":"Thompson","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1855","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.2000.00915.x","article-title":"Differential sensitivity to zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus","author":"Thomson","year":"2000","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1860","article-title":"Neuronal circuits for fear and anxiety","author":"Tovote","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1865","doi-asserted-by":"crossref","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1870","doi-asserted-by":"crossref","DOI":"10.1177\/0269881109358204","article-title":"Decreased GABAA and GABAB receptor functional activity in cannabinoid CB1 receptor knockout mice","author":"Urig\u00fcen","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1875","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2004.01.003","article-title":"Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors","author":"Urig\u00fcen","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1880","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhac220","article-title":"Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex","author":"Uzuneser","year":"2023","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1885","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2007.11.062","article-title":"Convergent regulation of locus coeruleus activity as an adaptive response to stress","author":"Valentino","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1890","doi-asserted-by":"crossref","DOI":"10.1046\/j.1460-9568.2002.1671407.x","article-title":"Effects of transgenic overproduction of CRH on anxiety-like behaviour","author":"Van Gaalen","year":"2002","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1895","doi-asserted-by":"crossref","DOI":"10.1126\/science.1115740","article-title":"Neuroscience: Identification and functional characterization of brainstem cannabinoid CB2 receptors","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1900","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0704201","article-title":"Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism","author":"Vargas","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1905","article-title":"Differences in NMDA receptor antagonist-induced locomotor activity and [3H]MK-801 binding sites in short-sleep and long-sleep mice","author":"Velardo","year":"1998","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1910","doi-asserted-by":"crossref","DOI":"10.1002\/syn.10279","article-title":"Differential projections of the infralimbic and prelimbic cortex in the rat","author":"Vertes","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002194","article-title":"Cognitive impairment induced by delta9- tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptors","author":"Vi\u00f1als","year":"2015","journal-title":"PLoS Biology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1920","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","author":"Viveros","year":"2005","journal-title":"Pharmacology Biochemistry and Behavior."},{"key":"10.1016\/j.pharmthera.2025.108799_bb1925","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-0346-0226-6_3","article-title":"Distribution of GABAA receptor subunits in the human brain","author":"Waldvogel","year":"2010","journal-title":"GABA and Sleep: Molecular, Functional and Clinical Aspects"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1930","article-title":"Association between TRP channels and glutamatergic synapse gene polymorphisms and migraine and the comorbidities anxiety and depression in a Chinese population","author":"Wang","year":"2023","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1935","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.22","article-title":"Monoacylglycerol lipase inhibitors produce pro-or antidepressant responses via hippocampal CA1 GABAergic synapses","author":"Wang","year":"2017","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1940","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2007.04577.x","article-title":"The lack of CB1 receptors prevents neuroadapatations of both NMDA and GABAA receptors after chronic ethanol exposure","author":"Warnault","year":"2007","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1945","doi-asserted-by":"crossref","DOI":"10.1113\/jphysiol.1995.sp020698","article-title":"Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone","author":"Watts","year":"1995","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1950","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-024-04027-5","article-title":"Astrocyte activation in the ACC contributes to comorbid anxiety in chronic inflammatory pain and involves in the excitation-inhibition imbalance","author":"Wei","year":"2024","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1955","doi-asserted-by":"crossref","DOI":"10.1159\/000126646","article-title":"Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat","author":"Weidenfeld","year":"1994","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1960","doi-asserted-by":"crossref","DOI":"10.1159\/000074882","article-title":"The endogenous cannabinoid, anandamide, activates the hypothalamo- pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice","author":"Wenger","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1965","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15628-7","article-title":"\u03b1 subunits in GABAA receptors are dispensable for GABA and diazepam action","author":"Wongsamitkul","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1970","author":"World Health Organization (WHO)"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1975","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.107958","article-title":"Application of ensemble learning for predicting GABAA receptor agonists","author":"Xiao","year":"2024","journal-title":"Computers in Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1980","article-title":"Microglial cannabinoid CB2 receptors in pain modulation","author":"Xu","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1985","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16293","article-title":"A quantitative pharmacology model for cannabinoid CB1 receptor mediated by Gi\/Gs protein competition","author":"Yang","year":"2024","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1990","article-title":"G protein coupling and activation of the metabotropic GABAB heterodimer","author":"Yang","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108799_bb1995","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1142055","article-title":"Activation of ventral tegmental area vesicular GABA transporter (Vgat) neurons alleviates social defeat stress-induced anxiety in APP\/PS1 mice","author":"Yao","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2000","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2011.10.013","article-title":"Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT 1A, GABA A, and NMDA receptors","author":"You","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2005","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2016.09.040","article-title":"Presynaptic protein synthesis is required for long-term plasticity of GABA release","author":"Younts","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2020.05.005","article-title":"Anterior cingulate cortex, insula and amygdala seed-based whole brain resting-state functional connectivity differentiates bipolar from unipolar depression","author":"Yu","year":"2020","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2015","article-title":"Time-dependent protection of CB2 receptor agonist in stroke","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","author":"Zhang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2025","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12367","article-title":"Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats","author":"Zhang","year":"2017","journal-title":"Addiction Biology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2030","doi-asserted-by":"crossref","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2035","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2014.24","article-title":"Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling","author":"Zhong","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2040","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12607","article-title":"Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice","author":"Zoppi","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2045","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-8993(02)03189-X","article-title":"Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat","author":"Zorrilla","year":"2002","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2050","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2015.06.021","article-title":"Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus","author":"Zou","year":"2015","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108799_bb2055","doi-asserted-by":"crossref","DOI":"10.1038\/nn1843","article-title":"Direct activation of the ion channel TRPA1 by Ca2+","author":"Zurborg","year":"2007","journal-title":"Nature Neuroscience"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:29:09Z","timestamp":1740691749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":411,"alternative-id":["S0163725825000117"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108799","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108799"}}